Eslicarbazepine acetate is an anticonvulsant used as a supplement to treat partial-onset seizures in patients who do not respond well to standard antiepileptic therapy. Eslicarbazepine acetate (ESL) is an anticonvulsant-approved drug used in Europe, the United States, and Canada as an adjunctive treatment for partial-onset seizures which have not reacted to primary therapy. Eslicarbazepine acetate is a prodrug that converts quickly to eslicarbazepine, the body's primary active metabolite. The mechanism of action of eslicarbazepine is unknown, but it is known that it has anticonvulsant properties by inhibiting repeated neuronal firing and stabilizing the inactivated state of voltage-gated sodium channels, preventing their activation and subsequent seizure activity. Aptiom is the brand name for eslicarbazepine acetate in North America, while Zebinix or Exalief is the brand name in Europe. It comes in 200, 400, 600, and 800 mg tablets, which are taken once a day with or without food. The side effects of eslicarbazepine acetate include lightheadedness, tiredness, nausea, puking, diarrhea, migraine, aphasia, loss of focus, psychomotor retardation, speech disturbances, ataxia, depressed mood, and hyponatremia. Suicidality should be monitored in patients who are taking eslicarbazepine acetate.

Eslicarbazepine acetate is broken down by the body into eslicarbazepine, which would be the form that helps prevent epileptic fits. Electrical activity in the brain may be too fast in some areas during a seizure. Eslicarbazepine works to prevent or stop seizures by slowing down electrical activity.

An online search for the wholesale price for the sale of Eslicarbazepine Acetate for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Eslicarbazepine Acetate distributors’ offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Eslicarbazepine Acetate suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Eslicarbazepine Acetate. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Eslicarbazepine Acetate is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or Eslicarbazepine Acetate suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Eslicarbazepine Acetate Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.